Literature DB >> 17078698

Synthesis of (+/-)-clusianone: high-yielding bridgehead and diketone substitutions by regioselective lithiation of enol ether derivatives of bicyclo[3.3.1]nonane-2,4,9-triones.

Vincent Rodeschini1, Nadia M Ahmad, Nigel S Simpkins.   

Abstract

[Structure: see text] A concise synthesis of the polyprenylated acylphloroglucinol natural product, clusianone, in racemic form, is described. An Effenburger cyclization generated a core bicyclo[3.3.1]nonane-trione structure, which was then elaborated by means of regioselective lithiation reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078698     DOI: 10.1021/ol0620592

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Total synthesis of (±)-7-epi-nemorosone.

Authors:  Qiang Zhang; John A Porco
Journal:  Org Lett       Date:  2012-03-26       Impact factor: 6.005

2.  The total synthesis of hyperpapuanone, hyperibone L, epi-clusianone and oblongifolin A.

Authors:  Nicole Biber; Katrin Möws; Bernd Plietker
Journal:  Nat Chem       Date:  2011-10-16       Impact factor: 24.427

3.  Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.

Authors:  Michelle R Garnsey; James A Matous; Jesse J Kwiek; Don M Coltart
Journal:  Bioorg Med Chem Lett       Date:  2011-02-23       Impact factor: 2.823

4.  Asymmetric, stereodivergent synthesis of (-)-clusianone utilizing a biomimetic cationic cyclization.

Authors:  Jonathan H Boyce; John A Porco
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-10       Impact factor: 15.336

5.  Synthetic Efforts Toward [3.3.1] Bridged Bicyclic Phloroglucinol Natural Products.

Authors:  Jon T Njardarson
Journal:  Tetrahedron       Date:  2011-10-07       Impact factor: 2.457

6.  Programmable meroterpene synthesis.

Authors:  Xingyu Shen; Chi P Ting; Gong Xu; Thomas J Maimone
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.